Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

43.23
-0.4200-0.96%
Post-market: 43.20-0.0300-0.07%19:59 EDT
Volume:17.94M
Turnover:776.02M
Market Cap:62.65B
PE:17.52
High:43.96
Open:43.51
Low:42.95
Close:43.65
52wk High:105.65
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:1.03
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.51
PE(LYR):22.28

Loading ...

Boston Scientific Says Cyberattack Likely to Hurt 2026 Sales, Profit Targets

Reuters
·
Sep 08

Movement Alert|Boston Scientific Falls 4.08% in Pre-Market Trading, Ongoing Cybersecurity Incident Continues to Disrupt Global Operations

Market Focus
·
Sep 08

Boston Scientific Corp: Company’s Sterilization Facilities are NOW Operational and Manufacturing Has Resumed Across Most Facilities Globally

THOMSON REUTERS
·
Sep 08

Boston Scientific Corp - no Evidence of Ongoing Unauthorized Access; Investigation Ongoing - SEC Filing

THOMSON REUTERS
·
Sep 08

Boston Scientific Corp - Identifies Cybersecurity Incident Causing Global Operational Disruption - SEC Filing

THOMSON REUTERS
·
Sep 08

Boston Scientific Corp - Unlikely to Meet Net Sales Growth and Adj EPS Guidance for Q3 and Full Year 2026 - SEC Filing

THOMSON REUTERS
·
Sep 08

Boston Scientific Corp - Incident not Expected to Have Material Impact on Long-Term Financial Condition - SEC Filing

THOMSON REUTERS
·
Sep 08

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 08

Just Like for SpaceX, Investors May Look to "Make Room" for AI Lab IPOs. These Stocks Could Pay the Price

Dow Jones
·
Sep 08

TD says Boston Scientific shipping update ‘big step forward’

TIPRANKS
·
Sep 05

Boston Scientific Corp. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04

Movement Alert|Boston Scientific Falls 3.04% in Regular Trading, Ongoing Cybersecurity Probe and FDA Highest-Severity Catheter Recall Weigh on Shares

Market Focus
·
Sep 04

FDA: as of May 27, 2026, Boston Scientific Reported 1,081 Serious Injuries and no Deaths Associated with Issue Related to Infinion Cx Leads

THOMSON REUTERS
·
Sep 04

FDA: Aware Boston Scientific Issued Letter to Affected Customers Recommending Unused Infinion Cx Leads be Removed from Where They are Used/Sold

THOMSON REUTERS
·
Sep 04

Boston Scientific’s LUX-Dx TRENDS Study Wraps Up, Raising New Signals for Heart Failure Investors

TIPRANKS
·
Sep 04

Movement Alert|Boston Scientific Rises 3.12% in Regular Trading, Extending Rebound After Cybersecurity Incident and Catheter Recall

Market Focus
·
Sep 02

Oncology Firm Novocure Says Cyberattack Exposed US Patient Records

Reuters
·
Sep 01

Medtronic Boosts Fiscal 2027 Forecasts on Heart Device Demand

Reuters
·
Sep 01

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Boston Scientific call volume above normal and directionally bullish

TIPRANKS
·
Sep 01